Follow
Yodit Fitsum
Yodit Fitsum
B.Pharm, Eritrean Pharmacoviglance Center, National Medicines and Food Administration
No verified email
Title
Cited by
Cited by
Year
Hydrochlorothiazide and risk of hearing disorder: a case series
N Belai, S Gebrehiwet, Y Fitsum, M Russom
Journal of medical case reports 12, 1-4, 2018
102018
Diclofenac and the Risk of Rhabdomyolysis: Analysis of Publications and the WHO Global Pharmacovigilance Database
M Russom, Y Fitsum, A Abraham, RL Savage
Drugs-Real World Outcomes 8, 263-275, 2021
42021
Tamsulosin and risk of priapism: A causality assessment using Austin Bradford Hill Criteria
M Russom, Y Fitsum, M Debesai, N Russom, M Bahta
Pharmacology Research & Perspectives 10 (2), e00934, 2022
32022
Knowledge, attitude and practice of antibiotics and their determinants in Eritrea
M Bahta, M Debesai, I Bahta, A Kessete, A Afendi, Y Fitsum, J Nambozi, ...
BMJ Open 11 (9), 2021
12021
Artesunate/Amodiaquine and risk of vision disorders: a case series
Y Fitsum, MH Werede, S Mihreteab, M Russom
EC Clin Med Case Rep 2 (8), 40-47, 2019
12019
Understanding, readiness, and response of healthcare professionals in combating falsified medical products in Eritrea: a population-based survey
Y Fitsum, A Werede, A Mahmud Saleh, EH Tesfamariam, F Magombo, ...
Therapeutic Advances in Drug Safety 14, 20420986231213713, 2023
2023
SARS-CoV-2 Associated Mucormycosis: Review of Epidemiology and Aetiology
Y Fitsum, Y Fitsum
EC Clinical and Medical Case Reports 4 (10), 12-18, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–7